Skip to main content

Can companies bring impaired assets back to life on the balance sheet?

An asset once written down—its value reduced to reflect diminished economic utility—normally stays diminished. A US company (GAAP) that impairs an asset in 2020 must live with that lower book value forever, or dispose of the asset. A European competitor (IFRS) that impairs the same asset in 2020 can reverse the impairment in 2023 if the asset's value recovers. The reversal is a gain that flows through net income, boosting earnings.

This asymmetry is a major fork in the accounting road. Reversal is not fraud; it is a principled accounting choice grounded in different views of conservatism and economic substance. But it creates opportunity for earnings management and distorts comparability. An IFRS company whose business is recovering can engineer a string of impairment reversals to offset operational challenges. A GAAP company in the same situation cannot.

This article explains the rules, the conditions that trigger reversals, and the red flags for investors.

Quick definition​

Impairment reversal is the reversal, in whole or part, of a prior write-down of an asset's book value. Under IFRS (IAS 36), when an asset's recoverable amount rises above its current carrying value, the excess may be reversed and recorded as a gain in net income (for goodwill, reversals are prohibited). Under GAAP (ASC 360), impairments are generally irreversible; once written down, an asset stays written down (or is eventually sold or retired).

Key takeaways​

  1. IFRS allows reversals; GAAP does not — IFRS IAS 36 permits reversal of impairments if the recoverable amount exceeds the current carrying value. GAAP ASC 360 prohibits reversals (except in rare business-combination circumstances).

  2. Reversals are non-cash gains — A reversal reverses a prior non-cash loss; both are book entries with no cash movement. This creates opportunity for cosmetic earnings boosts unmoored from operational improvement.

  3. Goodwill impairments cannot be reversed under either standard — Both IFRS and GAAP prohibit reversal of goodwill impairments, closing off the largest category of reversals.

  4. Reversals create earnings volatility and management discretion — Companies can time reversals strategically; an asset that recovered modestly in year 2 may not be formally impaired if the company is performing well, but formally reversed if earnings are weak.

  5. Recoverable amount is a key driver — Reversals depend on reassessment of fair value and value-in-use; changes in near-term assumptions (revenue growth, discount rates, commodity prices) can trigger reversals without operational change.

  6. Reversals most affect tangible and intangible assets, not goodwill — Buildings, equipment, patents, and customer lists can be reversed under IFRS; goodwill cannot. Investors should focus on non-goodwill impairment disclosures.

The mechanics of reversal​

An asset is impaired when its carrying value exceeds its recoverable amount. The recoverable amount is the higher of:

  1. Fair value less costs of disposal, or
  2. Value-in-use (the NPV of future cash flows the asset will generate).

A company recognises an impairment loss to write the carrying value down to the recoverable amount.

Under GAAP: the impairment is irreversible. Even if the asset's value later recovers, the carrying value stays low. The asset is not written back up.

Under IFRS: the company reverses the impairment if the recoverable amount rises above the current (post-impairment) carrying value. The reversal is recorded as a gain in net income, restoring the carrying value to the original amount or to the current recoverable amount, whichever is lower.

Example:

  • 2018: A company buys a mine for $100 million, carries it at $100 million.
  • 2020: Commodity prices collapse. The mine's value-in-use is assessed at $60 million. The company recognises an $40 million impairment loss. Carrying value drops to $60 million.
  • 2023: Commodity prices recover. The mine's value-in-use is now assessed at $85 million. Under IFRS, the company reverses $25 million of the impairment ($85 million new recoverable amount minus $60 million current carrying value). Carrying value rises to $85 million, and net income is boosted by $25 million.
  • Under GAAP: the reversal would not be recorded. Carrying value would remain at $60 million, even though the mine is now worth $85 million.

This is a fundamental difference in how the balance sheet is maintained.

Goodwill impairments—a special case​

Both IFRS and GAAP prohibit reversal of goodwill impairments. This is a rare point of convergence.

Goodwill, by definition, is the premium paid in an acquisition above the fair value of acquired tangible and identifiable intangible assets. It is highly subjective, and once impaired, it is assumed to be permanently lost. Allowing companies to reverse goodwill impairments would be seen as an open invitation to manipulate valuations.

So the reversal asymmetry applies almost entirely to tangible assets (buildings, equipment, land) and finite-life intangible assets (patents, customer lists, software). For goodwill, IFRS and GAAP converge on the irreversible rule.

But goodwill is the largest impairment category (most companies have substantial goodwill from acquisitions), so the practical impact of the IFRS reversal permission is smaller than it might appear. Many of the impairments investors see disclosed in footnotes are goodwill, and those cannot be reversed under either standard.

Why the IFRS permission exists​

The IASB's rationale for permitting reversals is economic substance. If an asset's value genuinely recovers, the balance sheet should reflect that recovery. Prohibiting reversals perpetuates a stale balance sheet that no longer matches economic reality. A building impaired in a downturn and now fully recovered in value should be shown at a value closer to its current market worth.

Additionally, IFRS prefers a "going-concern" view of asset values. Impairments are recognised when there is evidence of value loss; reversals are recognised when there is evidence of value recovery. Both are attempts to reflect the asset's current state.

The FASB's rationale for prohibiting reversals is conservatism and comparability. Once an asset is impaired, unlocking that impairment for upward reversal opens the door to management judgement. When is the asset's value recovery "real" and lasting, versus temporary? Prohibiting reversals eliminates that subjectivity. Additionally, the FASB views impairments as signal events that are typically triggered by structural, not temporary, deterioration. Once triggered, the asset's trajectory is often downward or to exit; reversals would be rare.

In practice, IFRS's flexibility is a double-edged sword. Companies can use reversals to smooth earnings, or to offset operational downturns with non-cash gains. A company facing weak operating performance in year 2 might opportunistically reverse an impairment recorded in year 1, boosting reported net income without any operational improvement.

Recoverable amount assumptions and volatility​

The recoverable amount is not a market price; it is an estimate based on management assumptions. For tangible assets, value-in-use is calculated using forecasts of future cash flows, discount rates, and terminal growth rates. For intangible assets (patents, customer lists), the same approach applies.

This is where discretion lives. A small change in assumptions can swing the recoverable amount. A company might:

  • Lower the discount rate (WACC) to inflate the NPV of future cash flows, raising recoverable amount.
  • Increase the forecast revenue growth rate for years 2–5, again raising the NPV.
  • Increase the terminal growth rate, lifting the perpetual tail value.

All of these are defensible changes; none are fraud. But they create opportunity for strategic timing of impairment reversals.

Example: A software company impairs a customer-relationship intangible asset in 2021 (due to customer churn). In 2023, churn stabilises, but revenue growth is still weak. The company reassesses the asset's value-in-use, lowering the discount rate from 10% to 8% (claiming lower risk now that the business is stable) and modestly raising the terminal growth rate. This pushes the recoverable amount above the current carrying value, triggering a reversal.

Is the reversal justified? Possibly; the reduced discount rate and improved customer retention could be real. But it is also cosmetic earnings uplift driven by assumption changes, not operational performance.

The reversal cap under IFRS​

IFRS imposes one important constraint: an asset's carrying value after reversal cannot exceed the amount that would have been recognised if the original impairment had never occurred (less accumulated depreciation since the original measurement date).

Example: A building was acquired in 2015 for $100 million with a 40-year life. By 2020, accumulated depreciation is $12.5 million, and the carrying value is $87.5 million. A $20 million impairment is recognised, dropping the carrying value to $67.5 million.

In 2023, the recoverable amount is assessed at $90 million. The reversal is capped at $20 million (the original impairment), restoring the carrying value to $87.5 million, not to $90 million. The company cannot use the reversal to write the asset above the pre-impairment carrying value (adjusted for depreciation).

This cap is a guard against unlimited upward revaluation through reversal. But it still permits reversals up to the original impairment amount, which can be substantial.

Real-world examples​

Rio Tinto and mining impairments: During the 2015–2016 commodity crash, Rio Tinto and other miners impaired large swaths of assets. In the subsequent recovery (2017–2021), Rio Tinto, an IFRS reporter, recognised material impairment reversals as commodity prices and long-term forecasts improved. These reversals were non-cash gains that boosted reported earnings. A US mining peer impaired assets similarly but could not reverse them, keeping balance-sheet valuations and earnings lower during the recovery.

European utilities: Companies like EDF (France) and Enel (Italy), both IFRS reporters with large asset bases (nuclear plants, distribution networks), have used impairment reversals to smooth earnings during regulatory or market downturns. When profitability pressures ease, the companies reverse prior impairments, releasing non-cash gains to offset weak operating performance.

Insurance companies: European insurers hold large real-estate portfolios. During recessions, properties are impaired. During recoveries, impairments are reversed. The swings in non-cash gains and losses can dwarf reported underwriting profits.

Common mistakes​

  1. Treating impairment reversals as operational earnings — A reversal is non-cash and driven by estimate changes, not business performance. An investor who equates a reversal to revenue growth or margin expansion is missing the distinction.

  2. Ignoring the recoverable-amount assumption changes — When a company reverses an impairment, the footnote disclosure usually states the new recoverable amount and the revised assumptions. Reading these assumptions is critical; a lower discount rate or higher growth rate is often the driver, not operational improvement.

  3. Assuming reversals are always conservative — Some investors view reversals as prudent recognition of value recovery. In fact, reversals are opportunities for management discretion. A company under earnings pressure has incentive to time reversals to boost reported results.

  4. Confusing impairment with revaluation — Impairment (downward write-down) and revaluation (upward restatement to fair value) are different mechanisms. Revaluation occurs at fair-value assessment dates (e.g., annually); impairment occurs when there is evidence of loss. Reversals of impairments are different from revaluations, though both affect asset values.

  5. Overlooking that GAAP companies live with lower book values — A GAAP company in a recovering industry will show lower asset values (and lower equity) than an IFRS peer, purely because of the no-reversal rule. This is a balance-sheet effect, not a sign of weakness.

FAQ​

Q: If an asset is impaired under GAAP, can it ever be written up? A: No, not through the impairment or revaluation mechanism. However, if the asset is recorded in a later acquisition or restructuring at higher value, the acquisition accounting might reflect the higher value. But in the normal course, GAAP impairments are irreversible.

Q: Are impairment reversals always booked in net income? A: Under IFRS, most reversals flow through net income (as a reversal of the original impairment loss). However, if the original impairment was previously booked in other comprehensive income (OCI) due to revaluation, the reversal also flows through OCI. This is rare; most impairment reversals hit the P&L.

Q: How often do companies reverse impairments? A: Reversals are less frequent than initial impairments (because impairments are often triggered by structural changes, which are hard to reverse). However, reversals do occur, particularly in cyclical industries (mining, real estate, energy) when commodity prices or interest rates recover. Investors should scan the impairment footnote for reversal disclosures.

Q: Can a company reverse an impairment and then re-impair the same asset in the next year? A: Yes, though such yo-yoing is a red flag. If an asset's value is volatile and management is frequently reversing and re-impairing, it suggests either (a) the underlying business is highly cyclical, or (b) management is manipulating assumptions to smooth earnings. Either way, the impairment disclosures merit scrutiny.

Q: How do auditors police impairment reversals? A: Auditors challenge the recoverable-amount estimates, particularly the cash-flow forecasts and discount rates. If the auditor disagrees with management's assumptions, the impairment reversal is scaled back or rejected. In practice, disagreements are common, and auditor notes in the financial statement audit report may flag "critical audit matters" related to impairment assumptions.

Q: If I'm comparing an IFRS company to a GAAP company, should I adjust for reversals? A: Yes. Strip out impairment reversals from the IFRS company's net income to compare against the GAAP company on a more level footing. Alternatively, model what the GAAP company's earnings would have been if impairment reversals had been recognised (which they were not), to see the full impact.

  • Impairment testing under IAS 36 (IFRS) and ASC 360 (GAAP) — Understand the testing process, the definition of recoverable amount, and the triggers for impairment.
  • Value-in-use versus fair value — IFRS uses both concepts in impairment testing; understand the difference and why discount-rate assumptions are critical.
  • Goodwill impairment and the annual impairment test — Goodwill is tested at least annually; reversals are prohibited under both standards.
  • Revaluation versus impairment reversal — Related but distinct; revaluation resets the asset to fair value, while reversal restores a prior loss to the extent of recovery.
  • Critical audit matters (CAMs) in the auditor's report — Impairment assumptions are frequently flagged as CAMs; read the auditor's narrative.

Summary​

Impairment reversals under IFRS versus the no-reversal rule under GAAP represent a fundamental divide in accounting conservatism and flexibility. IFRS permits companies to reverse prior impairments when evidence supports value recovery, boosting net income with non-cash gains. GAAP locks in impairments permanently, maintaining conservative book values and eliminating the opportunity for reversal-driven earnings management.

For investors, the key is to recognise reversals as non-operational, discretionary gains driven by assumption changes in recoverable-amount estimates. A reversal does not indicate that the business has improved; it indicates that management's forecast of the asset's future cash generation has improved (or become more optimistic). Comparing IFRS and GAAP reporters requires stripping out reversals to see underlying operational performance.

Goodwill reversals are prohibited under both standards, so the reversal asymmetry affects only tangible and finite-life intangible assets. Investors should monitor impairment footnote disclosures for patterns of reversals, particularly in cyclical industries where value swings are large. A company with a history of aggressive reversal timing—releasing reversals when operational earnings are weak—may be using the tool as a smoothing mechanism rather than as a faithful reflection of economic reality.

Next​

Leases: ASC 842 vs IFRS 16